LB Pharmaceuticals (LBRX) Stock Chart & Stock Price History $15.71 -0.36 (-2.24%) As of 11:22 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock LB Pharmaceuticals Stock Price Performance The LB Pharmaceuticals (LBRX) stock chart highlights key performance trends across multiple timeframes. As of the latest close, LB Pharmaceuticals traded at $16.07 with a market cap of $360.66 million and volume of 144,462 shares. Receive LBRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LB Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.45% LBRX Stock Chart for Tuesday, October, 14, 2025 LBRX Chart by TradingView LB Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$15.44$16.07+4.08%$16.31$15.17144,462 shs$360.66 million10/10/2025$15.64$15.44-1.28%$16.08$14.87159,189 shs$346.52 million10/09/2025$15.04$15.64+3.99%$15.85$14.86261,016 shs$350.96 million10/08/2025$16.01$15.04-6.06%$16.30$14.92140,231 shs$337.50 million10/07/2025$15.14$16.01+5.75%$16.20$14.85248,868 shs$359.31 million10/06/2025$15.05$15.14+0.60%$16.56$14.65265,124 shs$339.74 million10/03/2025$15.46$15.05-2.65%$15.67$14.79258,637 shs$337.72 million10/02/2025$15.76$15.46-1.90%$16.29$14.90399,177 shs$346.92 million10/01/2025$15.79$15.76-0.19%$16.75$14.36487,338 shs$353.70 million09/30/2025$15.24$15.79+3.61%$16.01$13.40207,103 shs$354.33 million Get the Latest News and Ratings for LBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LB Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$15.44$15.24-1.30%$15.43$14.6157,853 shs$341.99 million09/26/2025$14.95$15.44+3.28%$15.76$13.36131,515 shs$346.47 million09/25/2025$15.00$14.95-0.33%$16.12$14.60216,494 shs$335.52 million09/24/2025$14.90$15.00+0.67%$15.40$14.6188,811 shs$336.60 million09/23/2025$16.02$14.90-6.99%$16.02$14.30215,275 shs$334.36 million09/22/2025N/A$16.02$16.28$15.03103,425 shs$0.00 Related Companies Syndax Pharmaceuticals Stock Price Chart Evotec Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Zymeworks Stock Price Chart Taysha Gene Therapies Stock Price Chart Oric Pharmaceuticals Stock Price Chart Sionna Therapeutics Stock Price Chart Xeris Biopharma Stock Price Chart Nuvation Bio Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Receive LBRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LB Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LBRX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LB Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share LB Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
